^
Association details:
Biomarker:No biomarker
Cancer:Kaposi Sarcoma
Drug:imatinib (YD312) (c-KIT inhibitor, SCF signal transduction pathway inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Kaposi Sarcoma: Useful under certain circumstances…Imatinib